A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
26 oct. 2020 08h00 HE
|
Resverlogix Corp
CALGARY, Alberta, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that its late-stage clinical candidate, apabetalone, has been...
Resverlogix 宣佈轉換 1,200 萬美元債權證以強化資產負債表
21 oct. 2020 03h48 HE
|
Resverlogix Corp
卡加利, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp.（「Resverlogix」或「公司」）(TSX:RVX) 今天宣佈，ORI Star Fund LP（「ORI」）的全資子公司 Vision Leader Limited 已發出轉換通知，準備將其 2019 年 9 月的所有債權證和相關利息轉換為 Resverlogix...
Resverlogix宣布转换1200万美元债券以增强资产负债表
21 oct. 2020 03h48 HE
|
Resverlogix Corp
卡尔加里, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp.（以下称“Resverlogix”或“公司”）（TSX：RVX）今天宣布，ORI Star Fund LP（以下称“ORI”）全资子公司Vision Leader...
Resverlogix Announces Presentations at Leading Scientific Conferences
15 oct. 2020 08h00 HE
|
Resverlogix Corp
CALGARY, Alberta, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today its participation during the following leading scientific...
Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
14 oct. 2020 07h30 HE
|
Resverlogix Corp
CALGARY, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that Vision Leader Limited, a wholly-owned subsidiary of ORI Star Fund LP...
Resverlogix Announces $13 Million Private Placement
06 oct. 2020 07h30 HE
|
Resverlogix Corp
CALGARY, Alberta, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has entered into a definitive stock purchase agreement for a...
Resverlogix Confirms Interim Filings on SEDAR
02 oct. 2020 18h14 HE
|
Resverlogix Corp
CALGARY, Alberta, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces that, further to its September 25, 2020 press release, it today has filed...
Resverlogix Provides Update Regarding Extension of its Filing Calendar
25 sept. 2020 18h30 HE
|
Resverlogix Corp
CALGARY, Alberta, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces that further to its September 11, 2020 press release, it continues to...
Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
15 sept. 2020 08h00 HE
|
Resverlogix Corp
CALGARY, Alberta, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: “Inhibitors of...
Resverlogix Provides Update Regarding Extension of its Filing Calendar
11 sept. 2020 20h18 HE
|
Resverlogix Corp
CALGARY, Alberta, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces that it has filed its annual financial statements for the year ended April...